Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Ernst Arne Høiby"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dag Torfoss, Harald Holte, Sigbjørn Smeland, Sunniva Fagerås Røst, Eldbjørg Vorkinn, Stein Kvaløy
Publikováno v:
Tidsskrift for Den norske legeforening.
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Ragnhild Halvorsen, Kirsti Vainio, Morten Tryland, Michael Tranulis, Lucy Robertson, Jan Erik Paulsen, Ørjan Olsvik, Karin Nygård, Truls Nesbakken, Judith Narvhus, Helle Margrete Meltzer, Bjørn-Tore Lunestad, Jørgen Lassen, Margaretha Haugen, Georg Kapperud, Ernst Arne Høiby, Livar Frøyland, Wenche Frølich, Lene Frost Andersen, Espen Rimstad
Publikováno v:
European Journal of Nutrition & Food Safety. :15-17
On 10. March 2006 , The Norwegian Food Safety Authority (Mattilsynet) decided that, on the basis of VKM’s previous risk assessment (2005), Nutramigen 1 with Lactobacillus rhamnosus GG (LGG) could not be marketed in Norway as medical foods for infan
Autor:
Ragnhild Halvorsen, Lucy J. Robertson, Jan Erik Paulsen, Livar Frøyland, Tore Midtvedt, Judith Narvhus, Truls Nesbakken, Wenche Frølich, Margaretha Haugen, Georg Kapperud, Siamak Yazdankhah, Bjørn Tore Lunestad, Ørjan Olsvik, Jørgen Fr Lassen, Lene Frost Andersen, Morten Tryland, Jarle Rugtveit, Michael A. Tranulis, Espen Rimstad, Ernst Arne Høiby, Helle Margrete Meltzer, Karin Nygård
Publikováno v:
European Journal of Nutrition & Food Safety. :58-60
The Norwegian Scientific Committee for Food Safety (VKM) has appointed an ad hoc-group of experts to answer a request from the Norwegian Food Safety Authority regarding benefit and risk assessment of B. lactis Bb12 in baby foods focusing on the age g
Autor:
Petter Brandtzaeg, Karianne Wiger Gammelsrud, Martin Steinbakk, Fredrik Müller, Per Kristian Knudsen, Ernst Arne Høiby, Jon Bohlin, Ørjan Samuelsen, Tore G. Abrahamsen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 11, p e0187618 (2017)
PLoS ONE, Vol 12, Iss 11, p e0187618 (2017)
Source at https://doi.org/10.1371/journal.pone.0187618 We prospectively studied the consequences of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in a cohort of children with cystic fibrosis (CF) and a cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e316cd59cdde7c15586249aac71194e9
http://hdl.handle.net/10852/62175
http://hdl.handle.net/10852/62175
Autor:
Stein Kvaløy, L. Sandvik, Peter Meyer, Jens Hammerstrøm, Tove Skjelbakken, A. K. Lehmann, Lorentz Brinch, Yngvar Fløisand, Ernst Arne Høiby, T. Fladhagen, E. Nyquist, Dag Torfoss, Fredrik Schjesvold, Harald Holte, J. Dalgaard
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 23(3)
In Norway, initial treatment of febrile neutropenia (FN) has traditionally been benzylpenicillin plus an aminoglycoside. Internationally, FN is often treated with a broad-spectrum β-lactam antibiotic. We aimed to compare these two regimens in a pros
Publikováno v:
Acta Oncologica. 51:433-440
The occurrence of antibiotic resistance and the use of broad-spectrum antibiotics are relatively low in Norway. The national recommendation in febrile neutropenia (FN) is prompt initial therapy with penicillin G plus an aminoglycoside. We sought to e
Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls
Autor:
Karianne Wiger Gammelsrud, L. Sandvik, Per Sandven, Peter Gaustad, Ernst Arne Høiby, Petter Brandtzaeg
Publikováno v:
Clinical Microbiology and Infection. 17(12):1875-1881
A longitudinal, prospective study was conducted intermittently in Norway, from 1999 to 2008, to investigate the Candida colonization rates and species distributions in the tonsillopharyngeal and faecal flora in: (i) children with cancer; (ii) childre